Anthony Petrone
Stock Analyst at Mizuho Securities
(4.54)
# 1,027
Out of 5,020 analysts
662
Total ratings
52.4%
Success rate
8.7%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COO The Cooper Companies | Reiterated: Buy | $85 → $75 | $57.41 | +30.64% | 40 | Sep 11, 2026 | |
| MDT Medtronic | Reiterated: Buy | $100 → $115 | $86.44 | +33.04% | 29 | Sep 2, 2026 | |
| MMED MiniMed Group | Reiterated: Buy | $21 → $26 | $19.60 | +32.65% | 4 | Sep 2, 2026 | |
| LIVN LivaNova | Reiterated: Buy | n/a | $74.70 | - | 29 | Aug 21, 2026 | |
| SWX: ALC Alcon Inc. | Reiterated: Buy | CHF 66.72 → CHF 70.89 | CHF 52.86 | +34.11% | 25 | Aug 13, 2026 | |
| HAE Haemonetics | Reiterated: Buy | $90 → $95 | $104.37 | -8.98% | 71 | Aug 11, 2026 | |
| RMD ResMed | Reiterated: Buy | $220 → $235 | $221.15 | +6.26% | 32 | Aug 11, 2026 | |
| PLSE Pulse Biosciences | Reiterated: Buy | $30 → $45 | $49.83 | -9.69% | 6 | Aug 10, 2026 | |
| DXCM DexCom | Reiterated: Buy | $95 | $86.23 | +10.17% | 14 | Aug 4, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Buy | $55 → $65 | $70.78 | -8.17% | 20 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 → $58 | $39.92 | +45.29% | 4 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $60 | $43.23 | +38.79% | 25 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 → $85 | $63.98 | +32.85% | 21 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $160 → $185 | $163.17 | +13.38% | 27 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $115 | $99.65 | +15.40% | 37 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 | $13.15 | +67.30% | 2 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $4.32 | +247.22% | 1 | Jul 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $17 | $9.93 | +71.20% | 34 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $105 | $63.04 | +66.56% | 31 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $105 | $85.19 | +23.25% | 30 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $525 → $400 | $401.24 | -0.31% | 18 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $18 | $9.96 | +80.72% | 6 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $140 → $145 | $126.11 | +14.98% | 23 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $24 → $20 | $16.50 | +21.21% | 8 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $22 → $27 | $22.38 | +20.64% | 31 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $7 | $3.95 | +77.22% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $12 → $5 | $5.79 | -13.64% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $8 | $4.64 | +72.41% | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $125 → $115 | $96.69 | +18.94% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $76.50 | +30.72% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $174.75 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $88.06 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 | $80.19 | n/a | 1 | Sep 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $1.25 | n/a | 3 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 | $75.46 | n/a | 7 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $16.09 | n/a | 1 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $4.19 | n/a | 1 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $18 | $18.49 | n/a | 8 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.000001 | n/a | 5 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $0.2672 | n/a | 7 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $95 | - | n/a | 4 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $93 | $196.62 | n/a | 1 | Aug 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $97 | $14.02 | n/a | 1 | Aug 2, 2016 |
The Cooper Companies
Sep 11, 2026
Reiterated: Buy
Price Target: $85 → $75
Current: $57.41
Upside: +30.64%
Medtronic
Sep 2, 2026
Reiterated: Buy
Price Target: $100 → $115
Current: $86.44
Upside: +33.04%
MiniMed Group
Sep 2, 2026
Reiterated: Buy
Price Target: $21 → $26
Current: $19.60
Upside: +32.65%
LivaNova
Aug 21, 2026
Reiterated: Buy
Price Target: n/a
Current: $74.70
Upside: -
Alcon Inc.
Aug 13, 2026
Reiterated: Buy
Price Target: CHF 66.72 → CHF 70.89
Current: CHF 52.86
Upside: +34.11%
Haemonetics
Aug 11, 2026
Reiterated: Buy
Price Target: $90 → $95
Current: $104.37
Upside: -8.98%
ResMed
Aug 11, 2026
Reiterated: Buy
Price Target: $220 → $235
Current: $221.15
Upside: +6.26%
Pulse Biosciences
Aug 10, 2026
Reiterated: Buy
Price Target: $30 → $45
Current: $49.83
Upside: -9.69%
DexCom
Aug 4, 2026
Reiterated: Buy
Price Target: $95
Current: $86.23
Upside: +10.17%
Inspire Medical Systems
Aug 4, 2026
Reiterated: Buy
Price Target: $55 → $65
Current: $70.78
Upside: -8.17%
Jul 31, 2026
Reiterated: Buy
Price Target: $55 → $58
Current: $39.92
Upside: +45.29%
Jul 31, 2026
Reiterated: Buy
Price Target: $70 → $60
Current: $43.23
Upside: +38.79%
Jul 31, 2026
Reiterated: Buy
Price Target: $80 → $85
Current: $63.98
Upside: +32.85%
Jul 31, 2026
Reiterated: Buy
Price Target: $160 → $185
Current: $163.17
Upside: +13.38%
Jul 29, 2026
Reiterated: Buy
Price Target: $120 → $115
Current: $99.65
Upside: +15.40%
Jul 28, 2026
Reiterated: Buy
Price Target: $22
Current: $13.15
Upside: +67.30%
Jul 17, 2026
Initiated Coverage: Buy
Price Target: $15
Current: $4.32
Upside: +247.22%
Jul 15, 2026
Reiterated: Buy
Price Target: $20 → $17
Current: $9.93
Upside: +71.20%
Jul 15, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $63.04
Upside: +66.56%
Jul 15, 2026
Reiterated: Buy
Price Target: $100 → $105
Current: $85.19
Upside: +23.25%
Jul 15, 2026
Reiterated: Hold
Price Target: $525 → $400
Current: $401.24
Upside: -0.31%
Jul 15, 2026
Reiterated: Buy
Price Target: $20 → $18
Current: $9.96
Upside: +80.72%
Jul 15, 2026
Reiterated: Hold
Price Target: $140 → $145
Current: $126.11
Upside: +14.98%
Jul 15, 2026
Reiterated: Hold
Price Target: $24 → $20
Current: $16.50
Upside: +21.21%
May 14, 2026
Reiterated: Hold
Price Target: $22 → $27
Current: $22.38
Upside: +20.64%
May 7, 2026
Reiterated: Buy
Price Target: $8 → $7
Current: $3.95
Upside: +77.22%
May 6, 2026
Reiterated: Hold
Price Target: $12 → $5
Current: $5.79
Upside: -13.64%
Apr 30, 2026
Reiterated: Buy
Price Target: $10 → $8
Current: $4.64
Upside: +72.41%
Apr 20, 2026
Reiterated: Hold
Price Target: $125 → $115
Current: $96.69
Upside: +18.94%
Apr 13, 2026
Reiterated: Buy
Price Target: $100
Current: $76.50
Upside: +30.72%
Jun 13, 2025
Reiterated: Buy
Price Target: $65
Current: $174.75
Upside: n/a
Nov 5, 2021
Reiterated: Buy
Price Target: $175
Current: $88.06
Upside: n/a
Sep 16, 2021
Rated: Buy
Price Target: $70
Current: $80.19
Upside: n/a
Aug 11, 2021
Rated: Buy
Price Target: $20
Current: $1.25
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $45
Current: $75.46
Upside: n/a
May 20, 2021
Rated: Buy
Price Target: $86
Current: $16.09
Upside: n/a
Sep 17, 2020
Initiated Coverage: Buy
Price Target: $15
Current: $4.19
Upside: n/a
Aug 13, 2020
Reiterated: Hold
Price Target: $25 → $18
Current: $18.49
Upside: n/a
Dec 3, 2019
Reiterated: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
Aug 17, 2018
Reiterated: Buy
Price Target: $7 → $6
Current: $0.2672
Upside: n/a
Mar 5, 2018
Reiterated: Hold
Price Target: $80 → $95
Current: -
Upside: n/a
Aug 25, 2017
Reiterated: Buy
Price Target: $93
Current: $196.62
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $97
Current: $14.02
Upside: n/a